Leisure-time physical activity and all-cause mortality among adults with intellectual disability: the National Health Interview Survey.
K M Diaz
https://pubmed.ncbi.nlm.nih.gov/31788881Actively Recruiting
Led by University of North Carolina, Chapel Hill · Updated on 2026-02-23
376
Participants Needed
2
Research Sites
26 weeks
Total Duration
U
University of North Carolina, Chapel Hill
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
Researchers are evaluating an inclusive physical activity program called PACE for adults with intellectual disability (ID) who do not show signs of Alzheimer's Disease or related dementias. This randomized controlled trial includes 120 adults with ID, their caregivers, and coaches, aiming to study the effects of physical activity on health and wellbeing in this population. The study is sponsored by the University of North Carolina, Chapel Hill. The study involves a 16-week intervention with weekly group fitness classes led by certified Inclusive Fitness Specialists. Participants in the intervention group will also use a web-based dashboard, attend weekly coaching meetings, and have access to web-based training for coaches and exercise professionals. Those in the waitlist control group will receive the PACE program after the initial 16-week period. The program is designed to encourage moderate-to-vigorous physical activity and community empowerment. Participants undergo screening and baseline assessments including cognitive testing, dementia screening, and physical activity monitoring with an Actigraph device worn for a week. Assessments include body composition scans, quality of life questionnaires, daily living skills, mental and cognitive functioning, emotional health, and physical fitness tests. Follow-up visits occur post-intervention and at 12 months to evaluate changes. The primary outcomes are steps per day and minutes of moderate-to-vigorous activity measured by the Actigraph at baseline and after 16 weeks.
CONDITIONS
Physical Activity and Community EmPOWERment Project
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit (in-person)
Duration - Up to 1 week
Participants and caregivers complete baseline assessments including cognitive testing, dementia screening, physical activity measurement using an Actigraph device, demographic information, and body composition measurement.
1 pre-assessment visit (in-person) and 7 days wearing an Actigraph device at home
Duration - 16 weeks
Participants engage in a 16-week inclusive exercise program consisting of weekly group fitness classes, weekly coaching meetings, web-based training for coaches, and daily/weekly interactions with an interactive web-based dashboard.
Weekly fitness classes and coaching meetings; daily/weekly dashboard interactions
Duration - 1 to 2 weeks
Participants repeat baseline assessments to measure changes after the intervention, including physical activity, body composition, cognitive and emotional functioning, and quality of life. A subset also completes interviews about their program experience.
1 post-assessment visit (in-person)
Duration - 12 months after intervention
Participants have a 12-month follow-up visit to reassess body composition and other long-term outcomes.
1 follow-up visit (in-person)
Total: 2 locations
1
University of Arkansas
Fayetteville, Arkansas, United States, 72701
Not Yet Recruiting
2
University of North Carolina
Chapel Hill, North Carolina, United States, 27517
Actively Recruiting
B
Brianne R Tomaszewski, PhD, MPH
K
Kara Hume, PhD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
K M Diaz
https://pubmed.ncbi.nlm.nih.gov/31788881Adrian De la Rosa, Gloria Olaso-Gonzalez, Coralie Arc-Chagnaud...
https://pubmed.ncbi.nlm.nih.gov/32780691Amanda Sinai, Ingrid Bohnen, Andre Strydom
https://pubmed.ncbi.nlm.nih.gov/22744404Shahin Shooshtari, Patricia Joan Martens, Charles A Burchill...
https://pubmed.ncbi.nlm.nih.gov/22295184